Table 6.

Multiple linear regression model for a relative increase of fluorescent product growth velocity (R factor) in the real-time CBA assay in asthma patients, considering all study variables.

Fluorescent Product Growth Velocity (R Factor)
	β (95% CI)	R2
FEV1, %	−0.21 (−0.34 to −0.07)	0.26
Red blood cell count, 106/μL	−0.26 (−0.39 to −0.12)
Citrulinated histone 3, ng/mL	0.35 (0.23 to 0.47)
Interleukin 6, BAL, pg/mL	0.19 (0.08 to 0.31)
Adjustment statistics	F = 5.04, p = 0.002

For data interpretation, see footnote to Table 3. For the abbreviations, see footnote to Table 2.